Emerging and High Growth Companies Emerging and High Growth Companies

The SRTX Group (Sheertex) in its transaction implemented under the Bankruptcy and Insolvency Act

SRTX Inc. and its affiliates (collectively, the SRTX Group), widely known for their rip-resistant tights marketed under the Sheertex brand, operate in the textile and apparel industry. As a result of certain liquidity issues, the SRTX Group launched a strategic review in October 2025 with a view...

Lead Office: Montreal Date Closed: February 26, 2026 Value: --

Taalas in its raising of US$169 million

On February 19, 2026, Taalas announced that it raised $169 million and developed a chip capable of using artificial intelligence applications faster and more cost effectively than traditional approaches. Taalas is an artificial intelligence chip startup based in Toronto. Osler, Hoskin &...

Lead Office: Toronto Date Announced: February 19, 2026 Value: US$169 million

Shakudo in its US$7-million financing

On February 17, 2026, Shakudo announced that it had completed a US$7-million financing round, led by Wittington Ventures. The financing will assist with the company’s expansion to the United States and launch of new products. Shakudo offers an end-to-end platform designed to help businesses...

Lead Office: Montreal Date Announced: February 17, 2026 Value: US$7 million

Modem in its closing of US$4.4-million Pre-Seed financing

On February 10, 2026, Modem announced it closed a US$4.4-million Pre-Seed financing round led by Accel, with participation from Inovia Capital and several angel investors. The company plans to utilize the funding to assist developers in shipping faster. Modem is an AI product management...

Lead Office: Toronto Date Announced: February 10, 2026 Value: US$4.4 million

Neo Financial in its $68.5-million equity financing

On February 3, 2026, Neo Financial announced that it secured $68.5 million in an oversubscribed round led by a syndicate of more than 100 Canadian founders, entrepreneurs and institutional investors, including Alberta Investment Management Corporation (AIMCo), Northleaf Capital Partners, Plaza...

Lead Office: Toronto Date Announced: February 3, 2026 Value: $68.5 million

Waabi in its US$1-billion financing

On January 28, 2026, Waabi announced that it secured US$1 billion in financing. This marks one of the largest funding rounds in Canadian tech history to date which consisted of a US$750-million Series C financing co-led by Khosla Ventures and G2 Venture Partners and an additional milestone-based...

Lead Office: Toronto Date Announced: January 28, 2026 Value: US$1 Billion

Mangrove Lithium in its US$85-million structured financing led by Canada Growth Fund and US$9-million ITC-backed loan underwritten by National Bank of Canada

On January 15, 2026, Mangrove Water Technologies Ltd. (Mangrove Lithium) announced an up to US$85-million structured financing led by Canada Growth Fund (CGF), with participation from existing investors, including Breakthrough Energy Ventures and BMW i Ventures. The financing closed alongside a...

Lead Office: Toronto Date Announced: January 15, 2026 Value: US$85 million

BioRender in Dimension Capital’s investment at a $900-million valuation

On December 18, 2025, BioRender announced that it facilitated a secondary purchase by Dimension Capital at a $900-million valuation. BioRender is a web-based platform that crafts and shares visually engaging scientific figures for communication and publication purposes. Osler, Hoskin &...

Lead Office: Toronto Date Announced: December 18, 2025 Value: $900 million

Pender Ventures in Science & Human’s $10-million Series A financing

On January 15, 2026, Science & Humans announced that it had raised $10 million of Series A financing. This amount includes $7 million in equity and $3 million in venture debt. Pender Ventures led the equity round with participation from Well Health Technologies, Michele Romanow and undisclosed...

Lead Office: Vancouver Date Announced: January 15, 2026 Value: $10 million

Genesys Capital in Enspire DBS Therapy’s $10.3-million Series B1 financing

On January 13, 2026,  Enspire DBS Therapy, Inc. announced that it raised $10.3 million in a Series B1 financing led by Genesys Capital. It also saw participation from existing investors Cleveland Clinic and JobsOhio Ventures. Genesys Capital invests in and builds companies in the...

Lead Office: Toronto Date Announced: January 13, 2026 Value: $10.3 million